Dyne Therapeutics
Price & Volume
Stats
See more52W Range | $6.36-$47.45 |
Market Cap | $1.2B |
Shares Short | 15M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$3.37 |
News
See moreYahoo Finance • 14 days ago
Dyne Therapeutics Announces Chief Business Officer and Chief Scientific Officer Appointments
Yahoo Finance • 15 days ago
Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance • last month
Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Chief Financial Officer
Yahoo Finance • last month
Dyne Therapeutics Announces Appointment of Erick J. Lucera as Chief Financial Officer
About
CEO | Mr. John G. Cox M.B.A. |
CFO | Mr. Erick J. Lucera C.F.A., CPA |
Address | 1560 Trapelo Road, Waltham, MA, United States, 02451 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 191 |
